In systemic sclerosis, where MIF may be involved in the amplifying proinflammatory loop leading to scleroderma tissue remodeling73, an MIF promoter polymorphism is associated with susceptibility to pulmonary arterial hypertension in diffuse cutaneous systemic sclerosis (SSc)74. Here, MIF is linked to systemic sclerosis.